Vanda Pharmaceuticals (VNDA) Leases (2019 - 2025)
Vanda Pharmaceuticals (VNDA) has disclosed Leases for 7 consecutive years, with $7.3 million as the latest value for Q4 2025.
- Quarterly Leases rose 31.08% to $7.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $7.3 million through Dec 2025, up 31.08% year-over-year, with the annual reading at $7.3 million for FY2025, 31.08% up from the prior year.
- Leases hit $7.3 million in Q4 2025 for Vanda Pharmaceuticals, up from $4.4 million in the prior quarter.
- In the past five years, Leases ranged from a high of $10.2 million in Q1 2021 to a low of $4.4 million in Q3 2025.
- Historically, Leases has averaged $7.5 million across 5 years, with a median of $7.6 million in 2023.
- Biggest YoY gain for Leases was 31.08% in 2025; the steepest drop was 27.39% in 2025.
- Year by year, Leases stood at $9.3 million in 2021, then decreased by 9.4% to $8.4 million in 2022, then fell by 15.44% to $7.1 million in 2023, then dropped by 21.13% to $5.6 million in 2024, then soared by 31.08% to $7.3 million in 2025.
- Business Quant data shows Leases for VNDA at $7.3 million in Q4 2025, $4.4 million in Q3 2025, and $5.2 million in Q2 2025.